Pharmaceutical companies hosting onsite inspections during the coronavirus pandemic should make them as remote as possible, US Food and Drug Administration officials suggested at the recent Parenteral Drug Association/FDA conference.
The advice comes as the agency gains experience with domestic site inspections, which it resumed in July in areas of...





